Balyasny Asset Management
KIDS icon

Balyasny Asset Management’s OrthoPediatrics KIDS Stock Holding History

Balyasny Asset Management’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
15,006
+109
+0.7% +$1.9K ﹤0.01% 2641
2025
Q4 		$265K Buy
+14,897
New +$261K ﹤0.01% 2780

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balyasny Asset Management's KIDS Position: Q1 2026 in Review

Balyasny Asset Management increased its OrthoPediatrics (KIDS) stake by 0.73% in Q1 2026, buying an estimated $1.9K and bringing the position to 15,006 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Balyasny Asset Management first reported a position in KIDS in Q4 2025 and has held it in 2 quarters since. The position peaked at $265K in Q4 2025. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Balyasny Asset Management held 15,006 shares of OrthoPediatrics worth $238K as of Q1 2026.
  • Balyasny Asset Management bought 109 OrthoPediatrics shares in Q1 2026, an estimated $1.9K.
  • OrthoPediatrics made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2641 holding.
  • Balyasny Asset Management first reported a position in OrthoPediatrics in Q4 2025 and has held it in 2 quarters since.
  • Balyasny Asset Management's OrthoPediatrics position peaked at $265K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.